Try our beta test site

Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 18, 2016 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
ClinicalTrials.gov Identifier:
NCT00044304
First received: August 24, 2002
Last updated: January 24, 2017
Last verified: April 18, 2016